游泳运动对儿童腺样体肥大干预效果及机制探究

发布时间：2018-11-01 13:34

【摘要】：目的:腺样体肥大是儿童常见的多发病,治疗起来比较困难,病情容易反复,长时间患病会影响儿童的身心健康发育,给孩子和家长带来极大的痛苦和负担。西医药物治疗副作用大,依附性强;西医手术治疗风险较高,病情易反复;中医药物治疗见效慢,用药困难。因此寻找一种不吃药不手术的治疗方法变得十分有现实意义。运动疗法能够提高人体机能,增强人体抵抗力,提高免疫系统功能。本文就是通过观察游泳运动对腺样体肥大的儿童病症的影响,与药物组进行对比试验,分析游泳运动对腺样体肥大的治疗机制,为临床研究提供理论参考。方法:本实验依托长春世纪游泳俱乐部融创馆、吉大一院及市儿童医院,选取2016年1月~4月在吉大一院及市医院耳鼻喉科进行门诊治疗的患病儿童36例。患病儿童最短患病4个月,最长患病14个月,年龄为6至8岁。实验准备期为4周,为2016年5月~6月,使实验对象游泳水平基本保持一致,然后进行分组。实验前将符合纳入标准的36名儿童按照患病程度随机平均分成2组:药物组和游泳组。实验期为2016年7月~12月,分成2个疗程,为1~10周,11~20周。药物组选取药物孟鲁司特钠片,化学名:白三稀受体拮抗剂(5mg),药物组儿童不进行专门的运动。游泳组制定合理有效的运动处方,游泳组的儿童不进行除游泳以外的其他运动,除极特殊情况不服用药物。分析两组患病儿童的腺样体体积积分、临床症状积分,淋巴细胞、中性粒细胞比例、肺活量,并对治疗效果进行总结分析,使用SPSS20.0统计软件进行数据处理。结果:(1)通过20周实验后,游泳组和药物组临床主要症状和次要症状的结果比较没有显著性差异P0.05,两组组内比较临床主要症状和次要症状的结果比较均具有显著性差异P0.05。(2)实验后,游泳组和药物组腺样体体积积分结果比较没有显著性差异,P0.05,两组组内比较腺样体体积积分结果比较均具有显著性差异,P0.05。(3)实验后,游泳组和药物组患病儿童的中性粒细胞比例都恢复到了正常水平。针对淋巴细胞比例,游泳组均都恢复到了正常水平,而药物组基本恢复到正常值。(4)实验后,游泳组和药物组的有效率和治愈率均较高,都达到了很好的治疗效果。(5)实验后,游泳组的儿童的肺活量明显高于药物组,具有显著性差异P0.01。结论:游泳运动能达到药物治疗的效果,且不存在副作用。长期药物治疗会降低人体免疫系统功能,而游泳运动增强的人体的呼吸系统机能,提高了人体免疫力,对儿童腺样体肥大症具有很好的治疗效果与干预机制。
[Abstract]:Objective: adenoid hypertrophy is a common frequent disease in children, which is difficult to treat and easy to repeat. It will affect the development of children's physical and mental health for a long time and bring great pain and burden to children and parents. Western medicine treatment of large side effects, strong dependence; Western surgery treatment risk is high, the disease is easy to repeat; traditional Chinese medicine treatment slow, difficult to use. Therefore, it is of great practical significance to find a treatment that does not take medicine or surgery. Exercise therapy can improve the function of human body, enhance human body resistance and improve the function of immune system. By observing the effect of swimming exercise on adenoid hypertrophy in children and comparing it with drug group, this paper analyzes the therapeutic mechanism of swimming exercise on adenoid hypertrophy, and provides a theoretical reference for clinical research. Methods: based on Changchun Century Swimming Club, Jida first Hospital and Children's Hospital, 36 children who were treated in the otolaryngology department and otolaryngology department from January to April 2016 were selected. Children with the disease have a minimum of 4 months and a maximum of 14 months, aged between 6 and 8 years. The preparation period of the experiment was 4 weeks, from May to June 2016. The swimming level of the subjects was basically the same, and then divided into groups. Before the experiment, 36 children who met the inclusion criteria were randomly divided into two groups according to the degree of illness: drug group and swimming group. The experimental period was from July to December, 2016, and was divided into two courses: 1: 10 weeks, 11: 20 weeks. Montelukast sodium tablets, chemical name: leukotriene receptor antagonist (5mg), were selected in the drug group, and children in the drug group were not given special exercise. The swimming group formulates reasonable and effective exercise prescriptions. Children in the swimming group do not exercise other than swimming and do not take drugs except in exceptional circumstances. The adenoid volume integral, clinical symptom score, lymphocyte, neutrophil ratio, vital capacity of the two groups were analyzed, and the therapeutic effect was summarized and analyzed. The data were processed by SPSS20.0 software. Results: (1) after 20 weeks of experiment, there was no significant difference between swimming group and drug group in the results of main clinical symptoms and secondary symptoms (P 0.05). There was significant difference between the main clinical symptoms and the secondary symptoms in the two groups (P 0.05). (2) after the experiment, there was no significant difference in the results of adenoid volume integral between the swimming group and the drug group. There were significant differences in the results of adenoid volume integral between the two groups. (3) after the experiment, the proportion of neutrophils in swimming group and drug group returned to normal level. According to the proportion of lymphocytes, the swimming group returned to the normal level, while the drug group basically returned to the normal value. (4) after the experiment, the effective rate and cure rate of the swimming group and the drug group were both higher. (5) after the experiment, the vital capacity of children in swimming group was significantly higher than that in drug group, with significant difference (P0.01). Conclusion: swimming exercise can achieve the effect of drug therapy, and there are no side effects. Long-term drug treatment can reduce the function of human immune system, while swimming can enhance human respiratory system function, improve human immunity, and have a good therapeutic effect and intervention mechanism for children with adenoid hypertrophy.
【学位授予单位】：吉林大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：G861.1

【参考文献】